Search research articles
Contact Us
Filters
Showing results (31-40 of 64) with videos related to
Page
of 7
Sort By:
Oncology (Williston Park, N.Y.)
|
July 12, 2002
Irinotecan and gemcitabine in patients with solid tumors: phase I trial
Caio Max Rocha Lima, Swan-Swan Leong, Carol A Sherman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2007
Video-assisted thoracic surgery lobectomy: report of CALGB 39802--a prospective, multi-institution feasibility study
Scott J Swanson, James E Herndon, Thomas A D'Amico, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 4, 2008
Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B Trial 9430
Thomas E Stinchcombe, Ann M Mauer, Lydia D Hodgson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2011
Cisplatin, irinotecan, and bevacizumab for untreated extensive-stage small-cell lung cancer: CALGB 30306, a phase II study
Neal E Ready, Arkadiusz Z Dudek, Herbert H Pang, et al.
Drugs - Real World Outcomes
|
October 18, 2016
First-Line Treatment with Bevacizumab and Platinum Doublet Combination in Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study in US Oncology Community Practices
Orsolya E Lunacsek, Arliene Ravelo, Anna D Coutinho, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 6, 2010
Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trial
Neal Ready, Pasi A Jänne, Jeffrey Bogart, et al.
Cancer
|
June 16, 2004
A phase I study of sequential administration of escalating doses of intravenous paclitaxel, oral topotecan, and fixed-dose oral etoposide in patients with solid tumors
Caio M S Rocha Lima, Carlo V Catapano, Daniel Pacheco, et al.
Cancer Investigation
|
August 29, 2002
Aberrant p53 staining does not predict cisplatin resistance in locally advanced non-small cell lung cancer
Elizabeth A Johnson, David S Klimstra, James E Herndon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 18, 2004
70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808
Jeffrey A Bogart, James E Herndon, Alan P Lyss, et al.
Annals of Surgical Oncology
|
November 13, 2015
Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer
Michael A Choti, Michele Thomas, Schiffon L Wong, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 64) with videos related to
Sort By:
Page
of 7
Oncology (Williston Park, N.Y.)
|
July 12, 2002
Irinotecan and gemcitabine in patients with solid tumors: phase I trial
Caio Max Rocha Lima, Swan-Swan Leong, Carol A Sherman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2007
Video-assisted thoracic surgery lobectomy: report of CALGB 39802--a prospective, multi-institution feasibility study
Scott J Swanson, James E Herndon, Thomas A D'Amico, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 4, 2008
Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B Trial 9430
Thomas E Stinchcombe, Ann M Mauer, Lydia D Hodgson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2011
Cisplatin, irinotecan, and bevacizumab for untreated extensive-stage small-cell lung cancer: CALGB 30306, a phase II study
Neal E Ready, Arkadiusz Z Dudek, Herbert H Pang, et al.
Drugs - Real World Outcomes
|
October 18, 2016
First-Line Treatment with Bevacizumab and Platinum Doublet Combination in Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study in US Oncology Community Practices
Orsolya E Lunacsek, Arliene Ravelo, Anna D Coutinho, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 6, 2010
Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trial
Neal Ready, Pasi A Jänne, Jeffrey Bogart, et al.
Cancer
|
June 16, 2004
A phase I study of sequential administration of escalating doses of intravenous paclitaxel, oral topotecan, and fixed-dose oral etoposide in patients with solid tumors
Caio M S Rocha Lima, Carlo V Catapano, Daniel Pacheco, et al.
Cancer Investigation
|
August 29, 2002
Aberrant p53 staining does not predict cisplatin resistance in locally advanced non-small cell lung cancer
Elizabeth A Johnson, David S Klimstra, James E Herndon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 18, 2004
70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808
Jeffrey A Bogart, James E Herndon, Alan P Lyss, et al.
Annals of Surgical Oncology
|
November 13, 2015
Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer
Michael A Choti, Michele Thomas, Schiffon L Wong, et al.
Page
of 7